
Sep 15, 2026
Cabaletta Bio (NASDAQ: CABA) Raises $128.2M from Warrant Exercises by September 12, 2026
Cabaletta Bio (NASDAQ: CABA) successfully raised approximately $128.2 million in gross proceeds from warrant exercises by their expiration on September 12, 2026. This significant capital influx included $115.0 million from the exercise of 46,011,900 warrants between July 1, 2026, and the expiration date. The warrants were originally issued during the company's June 2025 underwritten public offering, demonstrating successful capital mobilization for the biotechnology firm.
Company relevance
100.00%
Company sentiment
Bullish
Overall sentiment
Bullish